The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I-Reference-Cited by-同舟云学术

The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I

Published:1998-10 Issue:2 Volume:24 Page:85-95
ISSN:0169-4197
Container-title:International Journal of Pancreatology
language:en
Short-container-title:International Journal of Pancreatology

Author:

Kobari Masao,Kullenberg Björn,Björkman Anders,Matsuno Seiki,Ihse Ingemar,Axelson Jan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/BF02788565.pdf

Reference37 articles.

1. Nitecki SS, Sarr MG, Colby TV, van, Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas resection for ductal adenocarcinoma of the pancreas. Is it really improving?Ann Surg 1995; 221: 59–66.

2. Mao C, Domenico DR, Kim K, Hanson DJ, Howard JM. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies.Arch Surg 1995; 130: 125–134.

3. Gamou S, Kim YS, Shimizu N. Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, processing high number of EGF receptors.Mol Cell Endocrinol 1984; 37: 205–213.

4. Liebow C, Hierowski MT, du Sapin K. Hormonal control of pancreatic cancer growth.Pancreas 1986; 1: 44–48.

5. Korc M, Meltzer P, Trent J. Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer.Proc Natl Acad Sci USA 1986; 83: 5141–5144.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Design and Engineering of IgG-Like Bispecific Antibodies;Bispecific Antibodies;2011